The main purpose of this legislation is to reduce the out-of-pocket costs that Medicare beneficiaries have to pay for prescription drugs. It aims to limit the amount that individuals enrolled in Medicare Part D can be charged for their medications, making them more affordable. Key provisions of the legislation include a requirement that starting January 1, 2027, the cost-sharing for a month’s supply of covered prescription drugs cannot exceed the average net price of those drugs. This average net price is calculated based on what Medicare pays for the drugs, minus any rebates or discounts.